Bicycle Therapeutics PLC (BCYC) SEC Filings — 2025

Filings

• Bicycle Therapeutics' Losses Widen on Soaring R&D Costs — 10-Q · Oct 30, 2025
• Bicycle Therapeutics Announces Executive Changes and Board Appointments — 8-K · Sep 8, 2025
• Gilead to Acquire Bicycle Therapeutics for $1.5B — 8-K · Aug 8, 2025
• Bicycle Therapeutics' Q2 Loss Widens Amid R&D Spend — 10-Q · Aug 8, 2025
• Bicycle Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 17, 2025
• Bicycle Therapeutics Files 8-K Report — 8-K · May 1, 2025
• Bicycle Therapeutics Q1 2025: Revenue Up, Net Loss Continues — 10-Q · May 1, 2025
• Bicycle Therapeutics Files 8-K Report — 8-K · Apr 29, 2025
• Bicycle Therapeutics: Executive Compensation & Equity Awards Detailed — DEF 14A · Apr 23, 2025
• Bicycle Therapeutics Announces Director Changes and Compensation Updates — 8-K · Mar 27, 2025
• Bicycle Therapeutics Files 8-K on Shareholder Nominations — 8-K · Mar 14, 2025
• Bicycle Therapeutics Files 8-K on Financials — 8-K · Feb 25, 2025
• Bicycle Therapeutics Files 2024 10-K — 10-K · Feb 25, 2025
• Bicycle Therapeutics Files 8-K Report — 8-K · Jan 13, 2025